• Aucun résultat trouvé

ABBVIE INC. CALLS STOCKHOLDERS MEETING

N/A
N/A
Protected

Academic year: 2022

Partager "ABBVIE INC. CALLS STOCKHOLDERS MEETING"

Copied!
1
0
0

Texte intégral

(1)ABBVIE INC. CALLS STOCKHOLDERS MEETING NORTH CHICAGO, ILLINOIS, U.S.A., March 20, 2015 – AbbVie Inc. ("AbbVie") (NYSE / CHX / Euronext Paris / SIX: ABBV) today informs its stockholders that it is holding the 2015 Annual Meeting of Stockholders of AbbVie on Friday, May 8, 2015 at 9 AM (CT) at the Fairmont Chicago, Millennium Park, 200 North Columbus Drive, Chicago, Illinois 60601, U.S.A. AbbVie has established the close of business on March 11, 2015 as the record date for determining the registered stockholders entitled to attend, vote or grant proxies to vote at the meeting or any adjournments or postponements of the meeting. AbbVie makes available free of charge on its website, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, reports filed pursuant to Section 16 of the U.S. Securities Exchange Act of 1934 and amendments to those reports filed with or furnished to the SEC as soon as reasonably practicable after AbbVie electronically files these documents with, or furnishes them to, the SEC. These documents are posted on AbbVie’s website at www.abbvieinvestor.com. The SEC maintains a website that contains reports, proxy statements and other information regarding issuers that file electronically with the SEC. These materials may be obtained electronically by accessing the SEC’s home page at http://www.sec.gov. To obtain copies of AbbVie’s definitive proxy statement for its 2015 Annual Meeting, please consult AbbVie’s website at www.abbvieinvestor.com. Copies of the above referenced information will also be made available, free of charge, upon written request to AbbVie Inc., Investor Relations, 1 North Waukegan Road, North Chicago, Illinois 60064, U.S.A. SOURCE: AbbVie Inc.. WorldReginfo - f59912bb-a413-464e-b1a3-ef3afb6d1eef. CONTACT: AbbVie Inc., 1-847-938-8745.

(2)

Références

Documents relatifs

Important Additional Information This press release does not constitute an offer to purchase, or a solicitation of an offer to sell, shares of common stock of Pharmacyclics, nor is it

Important Additional Information This press release does not constitute an offer to purchase, or a solicitation of an offer to sell, shares of common stock of Pharmacyclics, nor is it

AbbVie makes available free of charge on its website, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, reports filed pursuant to Section

AbbVie makes available free of charge on its website, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, reports filed pursuant to Section

THE TENDER OFFER MATERIALS INCLUDING AN OFFER TO EXCHANGE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS AND THE SOLICITATION/RECOMMENDATION STATEMENT

The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most

As reported GAAP Adjusted for specified items: Intangible asset amortization Separation costs R&D Acquired IPR&D Calico collaboration Shire transaction costs Other As

These forward-looking statements are based on numerous assumptions and assessments made in light of AbbVie's experience and perception of historical trends, current conditions,